Asia On The Move: Chinese Mayor Joins BGI To Jumpstart Genome Project
This article was originally published in PharmAsia News
Executive Summary
Chinese officials including the mayor of Jining City have taken the plunge by lending their hands to healthcare firms navigating a complex regulatory scene. Meanwhile, two pharma executives have been detained in separate cases on charges of bribery and corruption, highlighting the lasting impact of an ongoing compliance crackdown on pharma companies in China.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Chinese Language Podcast: BIOSECURE Act, US PD-1 Approval, ADC Updates
Guest speaker and lawyer Kevin Duan joins Brian Yang and Dexter Yan to discuss the planned US BIOSECURE Act, the US approval of BeiGene's anti-PD-1 drug and the latest antibody-drug conjugates in development at Chinese pharma firms.
China Biotechs, CDMOs Embrace Uncertain Future, New Options Amid WuXi Woes
The shockwave of WuXi's withdrawal from BIO is ripping through the Chinese contract services sector. While some remain hopeful, others are preparing Plan B.